Immatics presenting at CIMT Annual Meeting 2022
May 10 - May 12, 2022
Join Immatics at the CIMT Annual Meeting to connect with the global cancer immunotherapy community in the heart of Europe.
Wednesday, May 11, 8:30 - 10:00 AM CEST
Plenary Session 3: Novel Targets
- Chairs: Harpreet Singh (Immatics, Tübingen, Germany), Sebastian Kreiter (TRON, Mainz, Germany)
Wednesday, May 11,3:30 - 5:30 AM CEST
Poster Session: Cellular Therapy
Claudia Wagner: “From bench to bedside: developing a PRAME-specific T cell receptor for an adoptive cell therapy approach" (abstract number: "132")
Steffen Walter: "Enhanced preclinical anti-tumor activity of PRAME-specific next-generation TCR-T cells through CD8αβ co-expression" (abstract number: "133")
Thursday, May 12, 9:00 - 10:30 AM CEST
Oral Talk Session: Cellular Therapy
- Martin Wermke: "Clinical outcomes of solid cancer patients treated with autologous TCR-T cells targeting PRAME in the ongoing ACTengine® IMA203 phase 1 dose escalation trial"
We are looking forward to meeting you!
For more information visit the event's homepage: CIMT-Meeting